Cite
HARVARD Citation
Higgins, P. et al. (n.d.). DOP39 Effect of baseline disease characteristics on clinical outcomes in moderate-to-severe Ulcerative Colitis treated with upadacitinib: Results from a Phase 3 trials programme. Journal of Crohn's and colitis. pp. i088-i089. [Online].